Viking Therapeutics’ new contract is a game changer. Here’s how much money it could bring in.
Analysts, who are highly bullish on the stock, have fretted for some time that Viking needed a partner to actually make the ...
Viking Therapeutics: No Buyout Needed Now
Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...
Investor's Business Daily on MSN8d
Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.
Viking Therapeutics stock toppled Tuesday after the biotech company inked a $150 million manufacturing deal for its weight-loss drug, VK2735.
Viking Therapeutics signs broad manufacturing agreement with CordenPharma
Viking Therapeutics (VKTX) announced that it has signed a broad, multi-year manufacturing agreement with CordenPharma, a contract development ...
AOL22d
Is Viking Therapeutics a Buy Right Now?
Viking Therapeutics (NASDAQ: VKTX) soared into the spotlight about a year ago when it delivered promising data on a drug candidate that aims to compete in an area of very high demand: weight loss.
Yahoo Finance15d
Viking Therapeutics to Participate at Upcoming Investor Conferences
A live webcast of the Leerink presentation may be accessed via a link on the Viking Therapeutics website in the Investors & Media section under Webcasts. Additionally, a replay of the webcast will ...